
Collagena Professional®Rosaintense AR Serum
Niacinamide And Hyaluronic Acid For Sensitive Skin
Any registered customer can rate a product, and a published review earns you 2 bonus points, whatever the rating. Reviews from accounts with a purchase on file are marked as a verified purchase.
Price for professionals

Collagena Professional®Collagen hydrolysate under patent No. 60945 of 1996, clinically tested. Developed by Eng. Tanya Roganska.The storyIntensive serum for reactive skin and rosacea. Restores skin barrier, reduces redness and improves microbiome with niacinamide and innovative cellular extracts.
Price for professionals
Already have an account? Sign in
All prices include VAT. Pay by bank transfer or cash on delivery, with no minimum order.
A staff account sees no customer prices and places no orders. The price list is in the dashboard.
Collagena Professional®Collagen hydrolysate under patent No. 60945 of 1996, clinically tested. Developed by Eng. Tanya Roganska.The storyOverview
Description
A serum for sensitive, redness-prone skin that soothes and reduces the look of redness. Collagen hydrolysate, niacinamide, hyaluronic acid and vitamin C reinforce the skin barrier and provide intense hydration, while Fresh Cells™ mango and Seboclear™ balance reactive skin.
Benefits
- Reduces redness and relieves rosacea - enhances cell functionality and strengthens skin barrier
- Provides deep hydration and restoration - with niacinamide, hyaluronic acid and vitamin C
- Brightens and balances reactive skin - Fresh Cells™ Mango PFE and Seboclear™-MP improve microbiome
- Long-lasting soothing effect - clean and functional formula for intensive nourishment and protection
Customer reviews
Any registered customer can write a review. The ones from accounts with a purchase of this product on file are marked as a verified purchase. A rating of stars alone from a verified purchase goes up at once; every other review is read before it is published. A published one earns 2 bonus points, whatever the rating.
Know this product? Sign in to rate it.







